Company attributes
Industry
B2X
CEO
Founder
Date Incorporated
2017
Number of Employees (Ranges)
1 – 10
Phone Number
+41445523888
Full Address
Anjarium Biosciences AG Wagistrasse 23 CH-8952 Schlieren
Founded Date
2017
Total Funding Amount (USD)
121,000,000
Latest Funding Round Date
September 16, 2021
Latest Funding Type
Patents Assigned (Count)
1
Country
Headquarters
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
61,000,000
Anjarium Biosciences AG is a genetic medicines company focused on creating and delivering a new generation of targeted gene therapies to patients. Anjarium’s versatile platform builds on novel therapeutic payloads and delivery technologies, with the aim to unlock the full potential of gene therapy.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
